Nov 9, 20224 min readAre Mid-Term Results Good for Biotech Investors?SUMMARY The drug-price reform focus of Congress affects biopharma stock prices The likelihood that Republicans will control at least the...
Jul 11, 20225 min readJune/July 2022 - Biotech Stocks Are Back?Biotech stocks are down ~40% since Jan 1, 2021, underperforming the broader markets The democratic white house and Congress since January...
